160 related articles for article (PubMed ID: 32490374)
1. Polymeric micelles loaded with carfilzomib increase tolerability in a humanized bone marrow-like scaffold mouse model.
Varela-Moreira A; van Straten D; van Leur HF; Ruiter RWJ; Deshantri AK; Hennink WE; Fens MHAM; Groen RWJ; Schiffelers RM
Int J Pharm X; 2020 Dec; 2():100049. PubMed ID: 32490374
[TBL] [Abstract][Full Text] [Related]
2. Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
Park JE; Chun SE; Reichel D; Min JS; Lee SC; Han S; Ryoo G; Oh Y; Park SH; Ryu HM; Kim KB; Lee HY; Bae SK; Bae Y; Lee W
PLoS One; 2017; 12(3):e0173247. PubMed ID: 28273121
[TBL] [Abstract][Full Text] [Related]
3. A6 Peptide-Tagged Core-Disulfide-Cross-Linked Micelles for Targeted Delivery of Proteasome Inhibitor Carfilzomib to Multiple Myeloma In Vivo.
Zhang C; Wang X; Cheng R; Zhong Z
Biomacromolecules; 2020 Jun; 21(6):2049-2059. PubMed ID: 32338875
[TBL] [Abstract][Full Text] [Related]
4. Polymer micelle formulations of proteasome inhibitor carfilzomib for improved metabolic stability and anticancer efficacy in human multiple myeloma and lung cancer cell lines.
Ao L; Reichel D; Hu D; Jeong H; Kim KB; Bae Y; Lee W
J Pharmacol Exp Ther; 2015 Nov; 355(2):168-73. PubMed ID: 26311812
[TBL] [Abstract][Full Text] [Related]
5. Utilizing in vitro drug release assays to predict in vivo drug retention in micelles.
Varela-Moreira A; van Leur H; Krijgsman D; Ecker V; Braun M; Buchner M; Fens MHAM; Hennink WE; Schiffelers RM
Int J Pharm; 2022 Apr; 618():121638. PubMed ID: 35257802
[TBL] [Abstract][Full Text] [Related]
6. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth.
Naksuriya O; Shi Y; van Nostrum CF; Anuchapreeda S; Hennink WE; Okonogi S
Eur J Pharm Biopharm; 2015 Aug; 94():501-12. PubMed ID: 26134273
[TBL] [Abstract][Full Text] [Related]
7. Effects of Organic Acids on Drug Release From Ternary Polypeptide Nanoparticles Entrapping Carfilzomib.
Jackson S; Agbana P; Kim KB; Bae Y
J Pharm Sci; 2022 Apr; 111(4):1172-1177. PubMed ID: 34551351
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Mediated Nanodrug of Proteasome Inhibitor Carfilzomib Boosts the Treatment of Multiple Myeloma.
Chen R; Yang J; Mao Y; Zhao X; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2023 Nov; 24(11):5371-5380. PubMed ID: 37801632
[TBL] [Abstract][Full Text] [Related]
9. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
Tam YT; Shin DH; Chen KE; Kwon GS
J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
[TBL] [Abstract][Full Text] [Related]
10. 3D Printing of Tricalcium Phosphate/Poly Lactic-co-glycolic Acid Scaffolds Loaded with Carfilzomib for Treating Critical-sized Rabbit Radial Bone Defects.
Li Y; Xie K; Wang C; Yang C; Huang K; Li F; Zheng C; Chen J; Dong S; Deng G; Huang G; Lu Q; Liu J; Li K; Tang Y; Wang L
Int J Bioprint; 2021; 7(4):405. PubMed ID: 34805594
[TBL] [Abstract][Full Text] [Related]
11. A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study.
Li Y; Yang F; Chen W; Liu J; Huang W; Jin M; Gao Z
Chem Pharm Bull (Tokyo); 2012; 60(9):1146-54. PubMed ID: 22976323
[TBL] [Abstract][Full Text] [Related]
12. Ternary Polypeptide Nanoparticles with Improved Encapsulation, Sustained Release, and Enhanced In Vitro Efficacy of Carfilzomib.
Agbana P; Lee MJ; Rychahou P; Kim KB; Bae Y
Pharm Res; 2020 Oct; 37(11):213. PubMed ID: 33025286
[TBL] [Abstract][Full Text] [Related]
13. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
[TBL] [Abstract][Full Text] [Related]
14. Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways.
Allegra A; Speciale A; Molonia MS; Guglielmo L; Musolino C; Ferlazzo G; Costa G; Saija A; Cimino F
Toxicol In Vitro; 2018 Mar; 47():186-194. PubMed ID: 29223572
[TBL] [Abstract][Full Text] [Related]
15. Effect of Formulation and Processing Parameters on the Size of mPEG- b-p(HPMA-Bz) Polymeric Micelles.
Bagheri M; Bresseleers J; Varela-Moreira A; Sandre O; Meeuwissen SA; Schiffelers RM; Metselaar JM; van Nostrum CF; van Hest JCM; Hennink WE
Langmuir; 2018 Dec; 34(50):15495-15506. PubMed ID: 30415546
[TBL] [Abstract][Full Text] [Related]
16. Scale-Up of the Manufacturing Process To Produce Docetaxel-Loaded mPEG-
Bresseleers J; Bagheri M; Storm G; Metselaar JM; Hennink WE; Meeuwissen SA; van Hest JCM
Org Process Res Dev; 2019 Dec; 23(12):2707-2715. PubMed ID: 32952390
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy.
Chu B; Shi S; Li X; Hu L; Shi L; Zhang H; Xu Q; Ye L; Lin G; Zhang N; Zhang X
Int J Pharm; 2016 Nov; 513(1-2):118-129. PubMed ID: 27596115
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Sensitizes Carfilzomib-Induced Apoptosis via Promoting Oxidative Stress in Multiple Myeloma Cells.
Li Q; Yue Y; Chen L; Xu C; Wang Y; Du L; Xue X; Liu Q; Wang Y; Fan F
Front Pharmacol; 2018; 9():334. PubMed ID: 29867453
[TBL] [Abstract][Full Text] [Related]
19. Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation.
Park JE; Park J; Jun Y; Oh Y; Ryoo G; Jeong YS; Gadalla HH; Min JS; Jo JH; Song MG; Kang KW; Bae SK; Yeo Y; Lee W
J Control Release; 2019 May; 302():148-159. PubMed ID: 30954620
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells.
Khonkarn R; Mankhetkorn S; Talelli M; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2012 Jun; 94():266-73. PubMed ID: 22377215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
